Wellnex Life (ASX:WNX) Investor Briefing & Q&A – 14th December 2023

December 14, 2023

Wellnex Life (ASX:WNX): Investor Briefing & Q&A with Managing Director Zack Bozinovski, CEO George Karafotias and Director Andrew Vidler

Reach Markets hosted a Q&A session with Managing Director Zack Bozinovski, CEO George Karafotias and Non-Executive Director Andrew Vidler which discussed the Pain Away acquisition and what it means for Wellnex.

The session also speaks about:

  • The refreshed Board team.
  • The agreements with leading providers such as Haleon, Arrotex and Chemist Warehouse.
  • The strategic focus over the next 12 months.

Recorded on 14th December 2023 (AEDT)

Join the next Wellnex Life webcast

Register to stay up to date with Wellnex Life

FEATURED SPEAKERS

Zack Bozinovski

Zack Bozinovski

Managing Director

Zack is a highly successful and seasoned executive in the Australian retail industry with over 35 years’ experience within FMCG and Pharmaceutical companies in Australia and internationally. Zack has previously held senior positions at Uncle Tobys/Goodman Fielder, PepsiCo and Sigma and successfully developed and established many brands in the Australian retail sector. Zack most recently held the position of Managing Director at Brands Solutions Australia. Zack was also a co-founder of Voost Vitamins, recently sold to Proctor & Gamble.

George Karafotias

George Karafotias

CEO

George is a specialist in restructuring, reinventing and implementing turnaround strategies for various ASX-listed companies with great success. His extensive experience includes an established track record with publicly-traded businesses, predominantly in senior executive positions. He is also a non-executive Director of Perpetual Resources Limited (ASX:PEC), and holds a Bachelor of Commerce degree from the University of Adelaide.

Andrew Vidler

Andrew Vidler

Non-Executive Director

Andrew Vidler has comprehensive experience across retail, consumer health products and retail pharmacy. Andrew in his over 30 years’ experience includes nearly 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where across many roles he led the Terry White and Chemmart pharmacy brands and the Endeavour consumer health products business. For the last 4 years Andrew worked for API Limited (now Wesfarmers Health) where he was responsible for the Priceline retail and Priceline pharmacy business. Andrew has an excellent track record of building strong team cultures while ensuring they say focused on the marketplace and building customers with an active preference for the products, brands and retailers he oversees.

Related Post